[ad_1]
Controversy has arisen in Europe over the Oxford-AstraZeneca corona vaccine, which has caused blood clots in some people. Several other countries, including Italy, have been reluctant to receive the vaccine. The World Health Organization (WHO) has held a press conference on this basis. On Friday (March 12), they said there was no evidence that the vaccine caused blood clots.
However, the company could not say with certainty that the use of this vaccine did not cause blood clotting side effects. Yesterday, the WHO hastily approved a dose of Johnson & Johnson vaccine for emergency use. Still, the vaccine is not cutting through the fog.
WHO spokeswoman Margaret Harris said: “Like other covid vaccines, the Oxford Covish field is a remarkable vaccine.” Harris believes that any concerns about tick protection need to be reviewed. “There are no restrictions on the use of the Oxford-Astrageneca vaccine,” he said. However, if there is any question about its safety, it should be investigated. But at the moment it is not correct to say that we will not use it.
Several countries, including Denmark, Norway, and Italy, canceled the AstraZeneca vaccination program. Thailand has recently suspended its vaccination program at Oxford. The country’s prime minister has canceled the vaccination campaign, although it was scheduled to start yesterday. Approximately 5 million people in Europe have already received the Oxford vaccine. Of these, 30 people showed signs of blood clots. The European Medical Agency (EMA) says there is no evidence that the tick caused the symptoms. And the benefits outweigh the risks.
Ittefaq / SA
[ad_2]
